Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
11.52
+0.55 (5.01%)
At close: Oct 7, 2025, 4:00 PM EDT
11.50
-0.02 (-0.17%)
After-hours: Oct 7, 2025, 7:30 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 274 employees as of December 31, 2024. The number of employees increased by 7 or 2.62% compared to the previous year.
Employees
274
Change (1Y)
7
Growth (1Y)
2.62%
Revenue / Employee
$206,803
Profits / Employee
-$791,051
Market Cap
2.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 274 | 7 | 2.62% |
| Dec 31, 2023 | 267 | -7 | -2.55% |
| Dec 31, 2022 | 274 | 46 | 20.18% |
| Dec 31, 2021 | 228 | 47 | 25.97% |
| Dec 31, 2020 | 181 | 20 | 12.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OCUL News
- 12 hours ago - Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - GlobeNewsWire
- 6 days ago - Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day Transcript - Seeking Alpha
- 7 days ago - Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock - GlobeNewsWire
- 7 days ago - Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint - GlobeNewsWire
- 4 weeks ago - Ocular Therapeutix, Inc. (OCUL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Ocular Therapeutix: A High-Stakes Bet On Becoming The New Standard Of Care - Seeking Alpha
- 2 months ago - Ocular Therapeutix, Inc. (OCUL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - GlobeNewsWire